Although the outcome of some of the trials was partially compromised by the complex nature of PCV2 infections, the large number of pigs involved (from 63 farms) and the variety of experimental and clinical conditions did show a reduction in the overall death rates of piglets related to circovirus infections of between 3.6% and 10%.